Small Stocks, Big Money

Por: RedChip Companies
RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.
118 episodios disponibles

Latest episodes of the podcast Small Stocks, Big Money

NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress 09/12/2025
Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource 02/12/2025
BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs 25/11/2025
Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech 18/11/2025
Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy 11/11/2025
FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity 04/11/2025
60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead 28/10/2025
Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon 21/10/2025
Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next! 14/10/2025
Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development 07/10/2025
Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio 09/09/2025
PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth 26/08/2025
Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential 19/08/2025
Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe 12/08/2025
Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy 05/08/2025
Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma 29/07/2025
Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook 22/07/2025
Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development 15/07/2025
Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy 08/07/2025
How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal 01/07/2025
1 2 3 ... 6 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA